Warning Letter Roundup: FDA Warns Five Firms for Quality Deficiencies

Drug GMP Report
A A
The FDA issued warnings to the following facilities in Australia, Korea, the European Union and the United States for deficiencies in records, documentation, GMPs, testing and validation:

To View This Article:

Login

Subscribe To Drug GMP Report